Preventing Preterm Birth: Exploring Innovative Solutions

doi:10.1016/j.clp.2024.02.006

Review

. 2024 Jun;51(2):497-510.

doi: 10.1016/j.clp.2024.02.006. Epub 2024 Mar 26.

Preventing Preterm Birth: Exploring Innovative Solutions

Affiliations

¹ Université de Montréal, Pavillion Roger-Gaudry, 2900 boul Edouard-Montpetit, H3T 1J4, Montréal, Québec, Canada; Centre de recherche du CHU Sainte-Justine, 3175 ch de la Côte-Sainte-Catherine, H3T 1C5, Montréal, Québec, Canada.
² Département de Biologie, Université de Sherbrooke, Voie 9, J1X 2X9, Sherbrooke, Québec, Canada.
³ Centre de recherche du CHU Sainte-Justine, 3175 ch de la Côte-Sainte-Catherine, H3T 1C5, Montréal, Québec, Canada; Department of Microbiology and Immunology, McGill University, 3775 Rue University, Room 511, H3A 2B4, Montréal, Québec, Canada.
⁴ Département de Chimie, Université de Montréal, Complexe des Sciences, 1375 avenue Thérèse-Lavoie-Roux, Montréal, Québec, H2V 0B3, Canada.
⁵ Departments of Obstetrics and Gynecology, Pediatrics, and Physiology, University of Alberta, 220 HMRC, T6G 2S2, Edmonton, Alberta, Canada.
⁶ Department of Obstetrics and Gynecology, Department of Immunology, Mayo Clinic, 200 First Street SW, Guggenheim Building 3rd floor, Rochester, MN 55905, USA.
⁷ Université de Montréal, Pavillion Roger-Gaudry, 2900 boul Edouard-Montpetit, H3T 1J4, Montréal, Québec, Canada; Centre de recherche du CHU Sainte-Justine, 3175 ch de la Côte-Sainte-Catherine, H3T 1C5, Montréal, Québec, Canada. Electronic address: sylvain.chemtob@umontreal.ca.

PMID: 38705654
DOI: 10.1016/j.clp.2024.02.006

Review

Preventing Preterm Birth: Exploring Innovative Solutions

Tiffany Habelrih et al. Clin Perinatol. 2024 Jun.

. 2024 Jun;51(2):497-510.

doi: 10.1016/j.clp.2024.02.006. Epub 2024 Mar 26.

Authors

Affiliations

¹ Université de Montréal, Pavillion Roger-Gaudry, 2900 boul Edouard-Montpetit, H3T 1J4, Montréal, Québec, Canada; Centre de recherche du CHU Sainte-Justine, 3175 ch de la Côte-Sainte-Catherine, H3T 1C5, Montréal, Québec, Canada.
² Département de Biologie, Université de Sherbrooke, Voie 9, J1X 2X9, Sherbrooke, Québec, Canada.
³ Centre de recherche du CHU Sainte-Justine, 3175 ch de la Côte-Sainte-Catherine, H3T 1C5, Montréal, Québec, Canada; Department of Microbiology and Immunology, McGill University, 3775 Rue University, Room 511, H3A 2B4, Montréal, Québec, Canada.
⁴ Département de Chimie, Université de Montréal, Complexe des Sciences, 1375 avenue Thérèse-Lavoie-Roux, Montréal, Québec, H2V 0B3, Canada.
⁵ Departments of Obstetrics and Gynecology, Pediatrics, and Physiology, University of Alberta, 220 HMRC, T6G 2S2, Edmonton, Alberta, Canada.
⁶ Department of Obstetrics and Gynecology, Department of Immunology, Mayo Clinic, 200 First Street SW, Guggenheim Building 3rd floor, Rochester, MN 55905, USA.
⁷ Université de Montréal, Pavillion Roger-Gaudry, 2900 boul Edouard-Montpetit, H3T 1J4, Montréal, Québec, Canada; Centre de recherche du CHU Sainte-Justine, 3175 ch de la Côte-Sainte-Catherine, H3T 1C5, Montréal, Québec, Canada. Electronic address: sylvain.chemtob@umontreal.ca.

PMID: 38705654
DOI: 10.1016/j.clp.2024.02.006

Abstract

This review examines the complexities of preterm birth (PTB), emphasizes the pivotal role of inflammation in the pathogenesis of preterm labor, and assesses current available interventions. Antibiotics, progesterone analogs, mechanical approaches, nonsteroidal anti-inflammatory drugs, and nutritional supplementation demonstrate a limited efficacy. Tocolytic agents, targeting uterine activity and contractility, inadequately prevent PTB by neglecting to act on uteroplacental inflammation. Emerging therapies targeting toll-like receptors, chemokines, and interleukin receptors exhibit promise in mitigating inflammation and preventing PTB.

Keywords: Inflammation; Neonatal outcome; Pathophysiology; Preterm birth; Preterm labor; Therapeutics; Tocolytics.

PubMed Disclaimer

Conflict of interest statement

Disclosure S. Chemtob and W.D. Lubell hold a patent on composition of matter for the use of 101.10/rytvela (IL-1 receptor antagonists, compositions, and methods of treatment, United States patent no. USPTO8618054, May 5, 2005). S Chemtob, WD Lubell, DM Olson, and S Girard hold a patent on methods for reducing perinatal morbidity and/or mortality (US20210322509, March 9, 2016).

Cited by

Monocytes and cervical ripening: a narrative review of prolonged labor pathophysiology.
Obeagu EI, Mahmoud SA. Obeagu EI, et al. Ann Med Surg (Lond). 2025 May 21;87(6):3289-3299. doi: 10.1097/MS9.0000000000003004. eCollection 2025 Jun. Ann Med Surg (Lond). 2025. PMID: 40486626 Free PMC article. Review.
A novel modulator of IL-6R prevents inflammation-induced preterm birth and improves newborn outcome.
Côté F, Prairie E, Sierra EM, Quiniou C, Habelrih T, Xu W, Ferri B, Hou X, Lahaie I, Côté N, Loiselle SE, Gobeil L, Sawaya K, Faucher A, Beaulieu A, Delisle S, Simard MP, Mohammad Nezhady MA, Laplante V, Reuben A, Kalaidji SM, Bajon E, Cagnone G, Leimert KB, Gauchat JF, Gaudreau L, Robertson S, Lubell WD, Olson DM, Chemtob S. Côté F, et al. EMBO Mol Med. 2025 Aug;17(8):1950-1982. doi: 10.1038/s44321-025-00257-9. Epub 2025 Jul 3. EMBO Mol Med. 2025. PMID: 40610814 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Preventing Preterm Birth: Exploring Innovative Solutions

Affiliations

Preventing Preterm Birth: Exploring Innovative Solutions

Authors

Affiliations

Abstract

Conflict of interest statement

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Abstract

Conflict of interest statement

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources